Concepedia

AM Swart

AS

Statistics

Publications

3

Citations

171

H-Index

3

Active since

2010

AM Swart is an author specializing in medicine, oncology, and gynecologic oncology.

Publications per year

2010–2013

3

Publications

3

Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: Results of the ICON6 trial

JA Ledermann, Timothy Perren, FA Raja et al. · UCL Discovery (University College London) · 2013 · 102 citations

Medicine, Gynecology, Oncology +17

ICON7: A PHASE III RANDOMISED GYNAECOLOGIC CANCER INTERGROUP TRIAL OF CONCURRENT BEVACIZUMAB AND CHEMOTHERAPY FOLLOWED BY MAINTENANCE BEVACIZUMAB, VERSUS CHEMOTHERAPY ALONE IN WOMEN WITH NEWLY DIAGNOSED EPITHELIAL OVARIAN (EOC), PRIMARY PERITONEAL (PPC) OR FALLOPIAN TUBE CANCER (FTC)

Timothy Perren, AM Swart, Jacobus Pfisterer et al. · UCL Discovery (University College London) · 2010 · 38 citations

Medicine, Gynecology, Oncology +11

ICON7: Final overall survival results in the GCIG phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer

AM Oza, Timothy Perren, AM Swart et al. · UCL Discovery (University College London) · 2013 · 31 citations

Medicine, Gynecology, Oncology +10

1–3 of 3